Correspondence to: Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients

Eamonn Maher; Frank Martiniuk; William Levis

doi:10.1111/all.15185

Correspondence to: Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients

Eamonn Maher
, Frank Martiniuk
, William Levis

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1073-1074
Number of pages	2
Journal	Allergy: European Journal of Allergy and Clinical Immunology
Volume	77
Issue number	3
DOIs	https://doi.org/10.1111/all.15185
State	Published - Mar 2022
Externally published	Yes

Bibliographical note

Funding Information:
No external funding for this manuscript.

Publisher link

10.1111/all.15185

Find It

Find It at U of M Libraries

Cite this

@article{ce5e592afe4b40b1b0740872b4c166e7,

title = "Correspondence to: Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients",

author = "Eamonn Maher and Frank Martiniuk and William Levis",

note = "Funding Information: No external funding for this manuscript.",

year = "2022",

month = mar,

doi = "10.1111/all.15185",

language = "English (US)",

volume = "77",

pages = "1073--1074",

journal = "Allergy: European Journal of Allergy and Clinical Immunology",

issn = "0105-4538",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "3",

}

TY - JOUR

T1 - Correspondence to

T2 - Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients

AU - Maher, Eamonn

AU - Martiniuk, Frank

AU - Levis, William

N1 - Funding Information: No external funding for this manuscript.

PY - 2022/3

Y1 - 2022/3

UR - https://www.scopus.com/pages/publications/85125278723

UR - https://www.scopus.com/pages/publications/85125278723#tab=citedBy

U2 - 10.1111/all.15185

DO - 10.1111/all.15185

M3 - Letter

C2 - 35218045

AN - SCOPUS:85125278723

SN - 0105-4538

VL - 77

SP - 1073

EP - 1074

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

IS - 3

ER -

Correspondence to: Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients

Bibliographical note

Publisher link

Find It

Other files and links

Cite this